Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Issels Integrative Oncology is a specialized healthcare provider that offers integrative and alternative cancer treatments based on the protocols developed by Dr. Josef Issels. The center is recognized for its focus on non-toxic immunotherapies, including dendritic cell vaccines, natural killer (NK) cells, and lymphokine-activated killer (LAK) cells. Their treatment philosophy emphasizes a comprehensive approach, combining advanced cellular therapies with systemic support such as hyperthermia and nutritional protocols to treat various stages of cancer. Currently, the organization operates clinical facilities in Mexico and provides administrative and consultation services in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Issels Hospital.